SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-08-005071
Filing Date
2008-07-22
Accepted
2008-07-22 17:05:47
Documents
11
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 BIOGEN IDEC INC. b71135bie10vq.htm 10-Q 787095
2 EX-10.2 AMENDMENT TO BIOGEN, INC. 1985 NON-QUALIFIED STOCK OPTION PLAN DATED APR b71135biexv10w2.htm EX-10.2 3369
3 EX-10.3 AMENDMENT TO BIOGEN, INC. 1987 SCIENTIFIC BOARD STOCK OPTION PLAN DATED b71135biexv10w3.htm EX-10.3 3250
4 EX-10.4 AMENDMENT TO IDEC PHARMACEUTICALS CORPORATION 1988 STOCK OPTION PLAN DAT b71135biexv10w4.htm EX-10.4 3394
5 EX-10.5 AMENDMENT TO IDEC PHARMACEUTICALS CORPORATION 1993 NON-EMPLOYEE DIRECTOR b71135biexv10w5.htm EX-10.5 3338
6 EX-10.6 AMENDMENT TO BIOGEN IDEC INC. 2003 OMNIBUS EQUITY PLAN DATED APRIL 18, 2 b71135biexv10w6.htm EX-10.6 3301
7 EX-10.7 AMENDMENT TO BIOGEN IDEC INC. 2005 OMNIBUS EQUITY PLAN DATED APRIL 18, 2 b71135biexv10w7.htm EX-10.7 3311
8 EX-10.8 AMENDMENT TO BIOGEN IDEC INC. 2006 NON-EMPLOYEE DIRECTORS EQUITY PLAN DA b71135biexv10w8.htm EX-10.8 3230
9 EX-31.1 SECTION 302 CERTIFICATION OF CEO. b71135biexv31w1.htm EX-31.1 8082
10 EX-31.2 SECTION 302 CERTIFICATION OF CFO. b71135biexv31w2.htm EX-31.2 8089
11 EX-32.1 SECTION 906 CERTIFICATION OF CEO & CFO. b71135biexv32w1.htm EX-32.1 3478
  Complete submission text file 0000950135-08-005071.txt   831533
Mailing Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142 6176792000
BIOGEN IDEC INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19311 | Film No.: 08963910
SIC: 2836 Biological Products, (No Diagnostic Substances)